Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$213.86 - $277.87 $245,083 - $318,439
-1,146 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$271.6 - $314.21 $23,086 - $26,707
-85 Reduced 6.9%
1,146 $360,000
Q3 2021

Oct 12, 2021

SELL
$274.82 - $308.34 $77,224 - $86,643
-281 Reduced 18.58%
1,231 $346,000
Q2 2021

Jul 21, 2021

SELL
$251.87 - $278.14 $73,294 - $80,938
-291 Reduced 16.14%
1,512 $417,000
Q3 2020

Nov 02, 2020

SELL
$167.03 - $201.3 $6,681 - $8,052
-40 Reduced 2.17%
1,803 $339,000
Q2 2020

Aug 10, 2020

BUY
$113.31 - $182.44 $208,830 - $336,236
1,843 New
1,843 $306,000
Q1 2020

May 11, 2020

SELL
$104.32 - $195.28 $123,932 - $231,992
-1,188 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$163.48 - $173.61 $194,214 - $206,248
1,188 New
1,188 $200,000
Q3 2019

Nov 06, 2019

SELL
$159.77 - $178.1 $235,500 - $262,519
-1,474 Closed
0 $0
Q2 2019

Aug 06, 2019

SELL
$144.16 - $172.9 $5,622 - $6,743
-39 Reduced 2.58%
1,474 $254,000
Q1 2019

May 08, 2019

BUY
$123.7 - $156.3 $187,158 - $236,481
1,513 New
1,513 $231,000
Q4 2018

Feb 07, 2019

SELL
$120.82 - $174.09 $180,021 - $259,394
-1,490 Closed
0 $0
Q3 2018

Nov 05, 2018

SELL
$167.67 - $188.27 $20,958 - $23,533
-125 Reduced 7.74%
1,490 $258,000
Q2 2018

Aug 02, 2018

BUY
$160.33 - $189.41 $15,071 - $17,804
94 Added 6.18%
1,615 $289,000
Q1 2018

Apr 26, 2018

SELL
$161.53 - $178.11 $31,498 - $34,731
-195 Reduced 11.36%
1,521 $0
Q4 2017

Feb 01, 2018

SELL
$147.99 - $163.95 $37,145 - $41,151
-251 Reduced 12.76%
1,716 $273,000
Q4 2017

Jan 29, 2018

BUY
$147.99 - $163.95 $291,096 - $322,489
1,967
1,967 $282,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Ifg Advisory, LLC Portfolio

Follow Ifg Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ifg Advisory, LLC with notifications on news.